SECURITIES AND EXCHANGE COMMISSION
                     Washington, D.C.  20549


            NOTIFICATION OF LATE FILING OF FORM 10-Q
             For Fiscal Quarter Ended March 31, 1996

                Commission File Number:  0-13154
                      Cusip Number:  302904



PART I   --   Registrant Information

Full Name of Registrant:                FCS Laboratories, Inc.

Address of Principal Executive Office:  2330 S. Industrial Park Ave
                                        Tempe, Arizona  85282


PART II  --   Rules 12b-25 (b) and (c)


Registrant's quarterly report on Form 10-Q for fiscal quarter ended
March 31, 1996 could not be filed for the reasons described in
reasonable detail in Part III of this form.


PART III --   Narrative

The Company was unable to timely file its quarterly report on Form
10-Q for the fiscal quarter ended December 31, 1995.  The reason
for that delay were outlined in detail in the Company's
Notification of Late filing of Form 10-Q dated February 14, 1996,
and the Form 10-Q for the quarter ended December 31, 1995, which
was dated April 19, 1996.

As a result of the foregoing, the Company's quarterly report on
Form 10-Q for the fiscal quarter ended March 31, 1996 will also be
delayed.

The Company's inability to file timely can not be eliminated
without unreasonable effort or expense.  It is expected that the
subject quarterly report on Form 10-Q will be filed on or before
the fifth calendar day following the prescribed due date.






                               -1-
PART IV  --   Other Information

(1)  Name and telephone number of person to contact in regard to  
     this notification:

            Nicholas A. Gallo, III             (908) 782-3353

(2)  Have all other periodic reports required (under
     Section 13 or 15(d) of the Securities Exchange
     Act of 1934) during the preceding 12 months (or      /X/ Yes
     for such shorter period that the Registrant was
     required to file such reports) been filed?           / / No
     If the answer is no, identify reports(s)

(3)  Is it anticipated that any significant change in 
     results of operations from the corresponding
     period for the last fiscal year will be              / / Yes
     reflected by the earnings statement to be
     included in the subject report or portion            /X/ No
     thereof?  For more information, refer to the 
     quarterly report on Form 10-Q for the fiscal 
     quarter ended December 31, 1995, which was dated
     April 19, 1996.


                       
      If so, attach an explanation of the anti-
      cipated change, both narratively and
      quantitatively, and if appropriate, state
      the reason why a reasonable estimate of
      the results can not be made.


______________________________________________________________


                     FCS LABORATORIES, INC.
has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.

Date:  May 15, 1996             /S/ Nicholas A. Gallo, III

                                Nicholas A. Gallo, III
                                Chairman and member of
                                the Board of Directors
                                and President




                               -2-